18 March 2003

Oklahoma City, OK––Breathing Disorders Services, Inc. (BDS), a national home medical equipment provider with headquarters in Oklahoma City, has announced the opening of new home medical equipment (HME) offices in Colorado Springs, CO, Hemet, CA and Kingman, AZ. The new operations follow the company’s successful establishment of similar therapeutic services in Oklahoma, Texas and Virginia.
 

Through the new offices, BDS will provide in-home nasal continuous positive airway pressure (CPAP) equipment and support to persons diagnosed with obstructive sleep apnea (OSA) syndrome. OSA is a disorder in which a person repeatedly stops breathing during sleep. It can occur when muscles that control the tongue and soft palate relax and allow the upper airway to narrow or even become blocked. CPAP equipment delivers mildly pressurized air through a small nose mask, keeping the airway open. In most cases, CPAP therapy resolves OSA immediately, without the need for drugs or surgery.

Recent medical studies have established a direct correlation between certain sleep disorders, particularly OSA, and cardiovascular problems such as hypertension, stroke, coronary artery disease, myocardial infarction, pulmonary hypertension and congestive heart failure.
 

In addition to CPAP equipment, the new offices will offer bi-level therapy, oxygen therapy, nebulizers and other forms of in-home aids for allergy and asthma sufferers.

“These offices mark another milestone in our business plan to selectively establish and acquire HME operations in proximity to sleep diagnostic labs across the nation,” said an official company spokesperson from BDS. “There is a wide-spread need for our services, since nearly 40 million Americans are estimated to suffer from sleep disorders, though many of them are still undiagnosed.”

ABOUT BDS
Breathing Disorders Services (BDS) is a group of companies providing home medical equipment and e-commerce solutions to persons diagnosed with breathing disorders. Operating currently in six states, BDS is growing rapidly into other markets, while maintaining its original focus on respiratory disorders and sleep disordered breathing. By stressing customer education and support, BDS’s therapeutic methodology has achieved a level of therapy compliance that exceeds the national average by 78 percent.